Harley Street Dermatology
Dr Emanuela Campalani MB BCh, MRCP (London), MD is a UK-trained Consultant Dermatologist. She qualified from Queen's University of Belfast in 1999 and completed general medical training at the Royal Victoria Hospital in Belfast, and King's College Hospital in London.
Dr Campalani has been working exclusively in Dermatology since 2001. She completed her specialist training in London at the Royal London Hospital, Barts' and the London NHS Trust, Royal Free Hospital, and St Helier Hospital. Her NHS post is at Epsom and St Helier University Hospitals NHS Trust. Dr Campalani undertook research in the field of psoriasis at St John's Institute of Dermatology, Guy's and St Thomas' Hospitals, and was awarded an MD by the University of London in 2009. Her publications are listed below.
Dr Campalani diagnoses and treats all skin conditions both in adults and children, including psoriasis, eczema, other skin rashes, acne, pigmented lesions and skin cancer, hyperhidrosis (excessive sweating) and skin allergies. In addition she can offer professional advice on the use of Botox, and she carries out Botox injections for both medical and cosmetic purposes.
Warren RB, Smith RL, Campalani E, Eyre S, Smith CH, Barker JN, Worthington J, Griffiths CE. Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms. Br J Dermatol. 2009 Feb;160(2):438-41
Warren RB, Smith RL, Campalani E, Eyre S, Smith CH, Barker JN, Worthington J, Griffiths CE. Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis. J Invest Dermatol. 2008 Aug;128(8):1925-9
E Campalani, M Arenas, C Lewis, AM Marinaki, JNWN Barker, CH Smith. Polymorphisms in folate, pyrimidine and purine metabolic enzymes predict response to methotrexate in patients with chronic plaque psoriasis. J Invest Dermatol. 2007 Aug;127(8):1860-7
E Campalani, MH Allen, D Fairhurst, H Young, C Mendonca, DA Burden, CEM Griffiths, M Crook, JNWN Barker, CH Smith. Specific polymorphisms of the apolipoprotein E gene show association with chronic plaque and guttate psoriasis but do not have a role in disease response to acitretin treatment. Br J Dermatol. 2006 Feb;154(2):345-52
Young HS, Summers AM, Read IR, Fairhurst DA, Plant DJ, Campalani E, Smith CH, Barker JN, Detmar MJ, PEC Brenchley PE, Griffiths CE. Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis. J Invest Dermatol. 2006 Feb;126(2):453-459
RA Palmer, CB van de Pas, E Campalani, SL Walker, AR Young, JLM Hawk. "A simple method to assess severity of polymorphic light eruption". Br J Dermatol. 2004 Sep;151(3):645-52
Ormerod AD, E Campalani, Goodfield MJ; BAD Clinical Standards Unit. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol. 2010 May;162(5):952-63
E Campalani, SH Cliff. The management of acne scarring. MIMS 2010 March
E Campalani, JNWN Barker. The clinical genetics of psoriasis. Current genomics 2005 Feb;6(1):51-60
AP Cairns, SA Wright, JD Patton, E Campalani, AJ Taggart. "Rheumatology day care and the impact of biological therapies – the Belfast experience". Rheumatology (Oxford) 2002 Mar;41(3):356-7
F Worsnop, E Campalani. A case of hypertrichosis lanuginosa acquisita. Submitted to Br J Dermatol.
E Campalani, CAH Holden. Keratoacanthoma associated with the use of Imiquimod. Clin Exp Dermatol. In press
E Campalani, R Cerio, D Paige. A boy with persistent "atopic eczema" resistant to topical therapies. Clin Exp Dermatol. 2009 Dec;34(8):927-8
Walker SL, Lozewicz S, Sood R, Mann TA, Campalani E, Hubbard VG. Lupus vulgaris due to mycobacterium bovis bacillus Calmette-Guerin (BCG) at the site of previous BCG vaccination. Clin Exp Dermatol. 2009 oct;34(7):e213-5
E Campalani, E Higgins. Erythema nodosum migrans. Clin Exp Dermatol 2003 Nov;28(6):679-80
E Campalani, GK Meenagh, MB Finch. An interesting case of Herpes Zoster in rheumatoid arthritis. Ann Rheum Dis 2002 Feb;61(2):102